Active, not recruitingPhase 4NCT03997266
NICU Antibiotics and Outcomes Trial
Studying Necrotizing enterocolitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Michael Morowitz
- Intervention
- Ampicillin(drug)
- Enrollment
- 802 target
- Eligibility
- All sexes
- Timeline
- 2020 – 2027
Study locations (14)
- USA Children's and Women's Hospital, Mobile, Alabama, United States
- Sharp Mary Birch Hospital for Women & Newborns, San Diego, California, United States
- Yale University School of Medicine, New Haven, Connecticut, United States
- University of South Flordia Health, Tampa, Florida, United States
- University of Louisville Research Foundation Inc./Kosair Charities Pediatric Clinical Research Unit, Louisville, Kentucky, United States
- The Trustees of Columbia University in the City of New York, New York, New York, United States
- Golisano Children's Hospital at University of Rochester, Rochester, New York, United States
- Maria Fareri Children's Hospital at Westchester Medical Center, Valhalla, New York, United States
- Atrium Health Wake Forest Baptist, Winston-Salem, North Carolina, United States
- Penn State Medical College, Hershey, Pennsylvania, United States
- Pennsylvania Hospital/The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- Alfred I. duPont for Children of the Nemours Foundation, Philadelphia, Pennsylvania, United States
- Magee Womens Hospital, Pittsburgh, Pennsylvania, United States
- University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03997266 on ClinicalTrials.govOther trials for Necrotizing enterocolitis
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07490834Long-term Nutritional Impact of Necrotizing Enterocolitis in Premature Newborns.Central Hospital, Nancy, France
- RECRUITINGNCT07192393Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC).Imperial College London
- RECRUITINGNANCT06727877Predictive Diagnosis of Ulcero-Necrotizing EnteroColitis in Premature Babies Using an Artificial Intelligence Approach Based on Early Analysis of the Fecal MicrobiotaUniversity Hospital, Clermont-Ferrand
- RECRUITINGNCT06681129Study of Normal Intestinal Development and Disease in Premature and Term NeonatesBoston Children's Hospital
- ACTIVE NOT RECRUITINGNCT06850896Antibiotic Exposure on Gut Microbiota and Motility Establishment in NewbornsThe First Hospital of Jilin University
- RECRUITINGNCT07152106Amniotic Fluid & the Preterm GutMaxima Medical Center
- ACTIVE NOT RECRUITINGNANCT06908239Milk Temperature Control and Necrotizing Enterocolitis Risk in Extremely Preterm InfantsDaping Hospital and the Research Institute of Surgery of the Third Military Medical University
- RECRUITINGNANCT06672913Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter StudyBaskent University Ankara Hospital